Brown Brothers Harriman & Co’s Zomedica Corp. ZOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,466,532
Closed -$296K 1522
2024
Q4
$296K Hold
2,466,532
﹤0.01% 505
2024
Q3
$338K Hold
2,466,532
﹤0.01% 484
2024
Q2
$361K Hold
2,466,532
﹤0.01% 425
2024
Q1
$360K Hold
2,466,532
﹤0.01% 417
2023
Q4
$494K Hold
2,466,532
﹤0.01% 348
2023
Q3
$412K Buy
2,466,532
+181,000
+8% +$35.1K ﹤0.01% 367
2023
Q2
$457K Hold
2,285,532
﹤0.01% 339
2023
Q1
$484K Hold
2,285,532
﹤0.01% 346
2022
Q4
$373K Hold
2,285,532
﹤0.01% 356
2022
Q3
$482K Hold
2,285,532
﹤0.01% 314
2022
Q2
$503K Hold
2,285,532
﹤0.01% 313
2022
Q1
$770K Hold
2,285,532
0.01% 283
2021
Q4
$701 Hold
2,285,532
﹤0.01% 294
2021
Q3
$1.2K Hold
2,285,532
0.01% 208
2021
Q2
$1.9K Hold
2,285,532
0.01% 171
2021
Q1
$3.61K Buy
+2,285,532
New +$3.73M 0.02% 127

Other funds holding ZOM

Brown Brothers Harriman & Co's ZOM Position: Q1 2025 in Review

Brown Brothers Harriman & Co sold out of Zomedica Corp. (ZOM) in Q1 2025, closing a stake of 2,466,532 shares — an estimated $296K sold.

Brown Brothers Harriman & Co first reported a position in ZOM in Q1 2021 and held it in 16 quarters. The position peaked at $770K in Q1 2022. 23 funds tracked by Wall St. Rank hold ZOM as of Q1 2025.

  • Brown Brothers Harriman & Co reported no remaining Zomedica Corp. position as of Q1 2025 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 2,466,532 Zomedica Corp. shares in Q1 2025, an estimated $296K.
  • Brown Brothers Harriman & Co first reported a position in Zomedica Corp. in Q1 2021 and held it in 16 quarters.
  • Brown Brothers Harriman & Co's Zomedica Corp. position peaked at $770K in Q1 2022.
  • 23 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2025.

Based on Brown Brothers Harriman & Co's 13F filing for Q1 2025, filed 14 May 2025.